Filter Results:
(64)
Show Results For
- All HBS Web
(935)
- People (2)
- News (64)
- Research (773)
- Events (1)
- Multimedia (2)
- Faculty Publications (664)
Show Results For
- All HBS Web
(935)
- People (2)
- News (64)
- Research (773)
- Events (1)
- Multimedia (2)
- Faculty Publications (664)
Sort by
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company headquartered in Egypt. The... View Details
- 15 Dec 2024
- News
After Ozempic
health, which are promising but still speculative, each of these new applications would pile even more riches into the coffers of the nonprofit Novo Nordisk Foundation, which owns 28 percent of Novo Nordisk’s equity. The organizational structure is unusual for the... View Details
- 01 Jan 2004
- News
Donald P. Nielsen, MBA 1963
art of the deal, replicated the Hazleton model, acquiring twenty companies and amalgamating the industry to create a global capability for the world's pharmaceutical makers. In 1987, with the View Details
- 01 Mar 2003
- News
Inside the Revolution
humanity discovered how to use fire,” says Enriquez’s colleague, HBS associate professor Jonathan West. West, who had been researching the semiconductor industry for some ten years, came to the life sciences field rather recently.... View Details
- 01 Jun 2000
- News
The Right Connections
resources -- what we call social capital." Organizational behaviorists have known for years that third-party endorsements are critical to a young firm's success. Higgins and Gulati wanted to understand the origins and nature of these important relationships. They... View Details
Keywords: Judith A. Ross
- 01 Jun 2000
- News
The Business of Biotech
is not a postdoc lab, this is a business. It's not enough just to do the experiment; somebody's got to take the ball and run with it." Lately, competition in the biotech industry has become more heated than ever, as a steadily increasing... View Details
Keywords: Julia Hanna
- 01 Feb 2001
- News
Drilling Down
The news last October of Chevron's proposed acquisition of Texaco for $36 billion in stock was hardly surprising to industry analysts. The planned merger — which would streamline projects and save some $1.2 billion annually — was... View Details
- 01 Aug 2001
- News
Cleveland Global Alumni Conference a Sold-Out Success
& Co., kicked off the first plenary session with a quick overview of factors contributing to the U.S. pharmaceutical industry's success in competing in the global market. Among other ad- vantages, Gilmartin cited the U.S. government's... View Details
- 01 Dec 1996
- News
New Releases
computer industries, in which interfirm and international rivalries are intense. The other three consortia - Electric Power Research Institute (EPRI), Gas Research Institute (GRI), and Bell Communications Research (Bellcore) - draw their membership from regulated View Details
- 01 Dec 2003
- News
The Next Big Thing
life-sciences center of the world, by virtue of its unsurpassed “cluster” of world-renowned universities and teaching hospitals; medical-device, biotech, and pharmaceutical companies; financial firms; and skilled workers. “The leadership... View Details
- 01 Dec 2013
- News
Your Own Medicine
help build new muscle—had been one of several potential treatments the Secklers chased to no avail, often stuck following promising science to dead ends. That changed three years ago, when former pharmaceutical executive Gene Williams... View Details
- 01 Apr 1999
- News
Q & A: Confronting New Technologies: When Doing Right Is Wrong
industries or certain segments of the pharmaceutical business. But in many other industries - financial services, education, and health care, for instance - this analytical... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
Association’s conference held on campus in early November. The three-day conference included presentations by industry executives, government officials, and HBS faculty on topics ranging from trends in the biotech and View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
they know what disruptive innovation means, but I’ve found it’s often misunderstood. The simplest way to describe it — in a way that applies to health care or any industry — is innovation that transforms a product or service that... View Details
- 23 Aug 2018
- News
Healthcare Alumni Keep Learning Through Virtual Programming
Clubs News Clubs News No matter where they are in the world, members of the HBS Healthcare Alumni Association (HBSHAA) can connect with each other, hear from business leaders, and catch up on industry trends without ever leaving their... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
companies and has a financial stake in Moderna.) There was a dollars-and-cents logic to this, since the big rewards that can be had in the pharmaceutical industry come with big financial risks. “There’s... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
aspirations, purpose, and values, so that they work together as an aligned team." Dan Vasella finds that the skills he called upon as a practicing physician are equally useful in running one of the world's largest pharmaceutical... View Details
- 01 Jan 2008
- News
Jeffrey R. Immelt, MBA 1982
Jeff Immelt’s night table—Railway Age, Aviation Week, Broadcasting & Cable—represents just a few of the industries encompassed by General Electric, the company founded by Thomas Edison where Immelt is entering his ninth year as chairman... View Details
- 01 Sep 2008
- News
Mara Aspinall
that personalized medicine brings. This is particularly important in fast-moving diseases, where the window for a positive outcome is small. What aspects of their business model do pharmaceutical companies need to redesign to hasten the... View Details